Nov 11 Love0 Fitz Gate Portfolio Company March Biosciences Receives FDA RMAT Designation for Fast Track Review of its Cancer Therapy By Fitz Gate March Biosciences HOUSTON, Nov. 11, 2025 (GLOBE NEWSWIRE) -- March Biosciences (March Bio), a clinical stage biotechnology company developing…Read More
